Literature DB >> 28509068

The combined use of edaravone, diuretics, and nonsteroidal anti-inflammatory drugs caused acute kidney injury in an elderly patient with chronic kidney disease.

Guang Jian Liu1, Yun Fu Wang2, Yan Jun Zeng3, Li Ding2, Guo Jun Luo2, Li Ping Zhang4, Jian'e Zhang5.   

Abstract

The purpose of this study was to draw attention to the fact that the combined use of edaravone, diuretics, and nonsteroidal anti-inflammatory drugs (NSAIDs) may lead to acute kidney injury. This study was a case report of acute kidney injury resulting from the combined use of the aforementioned types of drugs. A 77-year-old male patient with chronic kidney disease (third stage) who was treated with a combination of edaravone, diuretics, and NSAIDs showed significantly increased blood urea nitrogen and creatinine. Interestingly, the blood urea nitrogen and creatinine levels returned to pretreatment levels after the medications were stopped. The patient's score on the Naranjo Adverse Drug Reaction Probability Scale was a nine, and the score on the Drug Interaction Probability Scale was a five. For elderly patients with chronic kidney disease, the combined use of edaravone, diuretics, and NSAIDs should be avoided.

Entities:  

Keywords:  Acute kidney injury; Adverse drug reactions; Chronic kidney disease

Year:  2012        PMID: 28509068      PMCID: PMC5413645          DOI: 10.1007/s13730-012-0022-5

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN: 2192-4449


  26 in total

1.  Proposal for a new tool to evaluate drug interaction cases.

Authors:  John R Horn; Philip D Hansten; Lingtak-Neander Chan
Journal:  Ann Pharmacother       Date:  2007-03-27       Impact factor: 3.154

2.  Drug interaction between itraconazole and bortezomib: exacerbation of peripheral neuropathy and thrombocytopenia induced by bortezomib.

Authors:  Takuya Iwamoto; Miki Ishibashi; Atsushi Fujieda; Masahiro Masuya; Naoyuki Katayama; Masahiro Okuda
Journal:  Pharmacotherapy       Date:  2010-07       Impact factor: 4.705

Review 3.  The US color Doppler in acute renal failure.

Authors:  G Nori; A Granata; G Leonardi; E Sicurezza; C Spata
Journal:  Minerva Urol Nefrol       Date:  2004-12       Impact factor: 3.720

4.  Symptomatic hypoglycemia associated with trimethoprim/sulfamethoxazole and repaglinide in a diabetic patient.

Authors:  Matthieu Roustit; Emeline Blondel; Céline Villier; Xavier Fonrose; Michel P Mallaret
Journal:  Ann Pharmacother       Date:  2010-03-02       Impact factor: 3.154

5.  Determinants for the prognosis of acute renal disorders that developed during or after treatment with edaravone.

Authors:  Akira Hishida
Journal:  Clin Exp Nephrol       Date:  2008-12-05       Impact factor: 2.801

6.  Ischemia heart disease and greater waist circumference are risk factors of renal function deterioration in male gout patients.

Authors:  Ben Yu-Jih Su; Han-Ming Lai; Chung-Jen Chen; Ying-Chou Chen; Chun-Kai Chiu; Ko-Ming Lin; Shan-Fu Yu; Tien-Tsai Cheng
Journal:  Clin Rheumatol       Date:  2007-11-20       Impact factor: 2.980

7.  The effects of the nonsteroidal anti-inflammatory drug diclofenac sodium on the rat kidney, and alteration by furosemide.

Authors:  Ayberk Besen; Fatih Kose; Saime Paydas; Gulfiliz Gonlusen; Tamer Inal; Ayse Dogan; Mustafa Kibar; Mustafa Balal
Journal:  Int Urol Nephrol       Date:  2008-11-25       Impact factor: 2.370

8.  Adverse effects of diclofenac sodium on renal parenchyma of adult albino rats.

Authors:  Talat Yasmeen; Ghulam Sarwar Qureshi; Sughra Perveen
Journal:  J Pak Med Assoc       Date:  2007-07       Impact factor: 0.781

9.  Clinical analysis of 207 patients who developed renal disorders during or after treatment with edaravone reported during post-marketing surveillance.

Authors:  Akira Hishida
Journal:  Clin Exp Nephrol       Date:  2007-12-21       Impact factor: 2.801

10.  Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury.

Authors:  Ravindra L Mehta; John A Kellum; Sudhir V Shah; Bruce A Molitoris; Claudio Ronco; David G Warnock; Adeera Levin
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

View more
  1 in total

1.  γ-Glutamylcysteine Alleviates Ischemic Stroke-Induced Neuronal Apoptosis by Inhibiting ROS-Mediated Endoplasmic Reticulum Stress.

Authors:  Hui-Qin Li; Sheng-Nan Xia; Si-Yi Xu; Pin-Yi Liu; Yue Gu; Xin-Yu Bao; Yun Xu; Xiang Cao
Journal:  Oxid Med Cell Longev       Date:  2021-11-16       Impact factor: 6.543

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.